Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L04AX09
|
| gptkbp:CASNumber |
2756-87-8
|
| gptkbp:eliminationHalfLife |
about 1 hour
|
| gptkbp:has_trade_name |
Bafiertam
|
| gptkbp:hasMolecularFormula |
C5H6O4
|
| gptkbp:hasUNII |
3A0HTP5B6A
|
| https://www.w3.org/2000/01/rdf-schema#label |
monomethyl fumarate
|
| gptkbp:is_prescription_drug_in |
gptkb:United_States
|
| gptkbp:IUPACName |
methyl (E)-but-2-enedioate
|
| gptkbp:mechanismOfAction |
activates Nrf2 pathway
|
| gptkbp:metabolism |
gptkb:dimethyl_fumarate
|
| gptkbp:PubChem_CID |
4574417
5464356 |
| gptkbp:relatedTo |
fumaric acid esters
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
flushing
gastrointestinal symptoms |
| gptkbp:usedFor |
multiple sclerosis
|
| gptkbp:bfsParent |
gptkb:dimethyl_fumarate
|
| gptkbp:bfsLayer |
7
|